Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00223236 · ClinicalTrials.gov registry record · Phase 3
Trial of Citicoline Therapy in Patients With Mania or Hypomania and Cocaine Abuse/Dependence
A Phase 3 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 44
- Enrollment target
NCT00223236 is a Phase 3 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 44 participants.
The verdict
NCT00223236, a Phase 3 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 44 participants
- Enrollment target
Study Summary
The purpose of this research is to determine if a citicoline supplement is associated with a reduction in cocaine use and craving in patients with bipolar disorder (a mental disorder marked by alternating periods of mania and depression) or schizoaffective disorder/bipolar type (a psychotic disturbance in which there is a mixture of schizophrenic and manic-depressive symptoms) and cocaine abuse/dependence. This research also wants to explore if citicoline supplements are associated with greater improvement in symptoms of mania and on memory and cognition (the mental faculty of perception, reasoning, and judgement) in these patients.
Interventions
- DRUG Placebo
- DRUG Citicoline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2010-07 |
| Est. Completion | 2012-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00223236
The ClinicalTrials.gov registry entry for NCT00223236 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00223236 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00223236 about?
NCT00223236 is a clinical study titled "Trial of Citicoline Therapy in Patients With Mania or Hypomania and Cocaine Abuse/Dependence". The purpose of this research is to determine if a citicoline supplement is associated with a reduction in cocaine use and craving in patients with bipolar disorder (a mental disorder marked by alternating periods of mania and depression) or schizoaffective disorder/bipolar type (a psychotic disturba...
What is the current status of trial NCT00223236?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 44 participants. The study started on 2010-07. Estimated completion is 2012-05.
What interventions are being tested in trial NCT00223236?
The interventions under investigation include: Placebo (DRUG), Citicoline (DRUG).
Who is sponsoring clinical trial NCT00223236?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.